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Introduction {#sec001}
============

The genomes of eukaryotic DNA viruses vary in complexity with respect to the number of genes they encode, and hence their dependence on host-cell functions. With the exception of poxviruses, all replicate in the cell nucleus and therefore utilize the nuclear machinery for the maintenance, replication, and expression of their genomes. The dynamic interactions between viral and cellular proteins and the viral genome, function to mediate the different steps in the life cycle of the virus, and hence determine the outcome of infection. These include interactions that mediate the entry of the genome into the nucleus, its expression and replication, and ultimately the packaging of nascent genomes in capsids.

Herpes simplex virus 1 (HSV-1) has a linear genome comprised of 152 kilobasepairs \[[@ppat.1004939.ref001],[@ppat.1004939.ref002]\]. It enters the nucleus from the capsid through pores in the nuclear envelope \[[@ppat.1004939.ref003]--[@ppat.1004939.ref005]\]. The genome then participates in a series of interactions that results in a nucleo-protein complex near ND10 structures \[[@ppat.1004939.ref006]\]. Here, the genome is susceptible to activities of the intrinsic cellular antiviral response. The genome also contains nicks and gaps, and these along with the genomic termini elicit a DNA damage response, the nature of which may be consequential to viral infection \[[@ppat.1004939.ref007]\]. Viral genomes initially associate with ND10 structures, where through the action of ICP0, ND10 proteins are degraded or dispersed resulting in the prerequisite structure for efficient transcription and replication \[[@ppat.1004939.ref006],[@ppat.1004939.ref008]\]. Viral DNA replication then results in the formation large replication compartments, which fill the host nucleus and concentrate viral and cellular factors to replicating viral genomes \[[@ppat.1004939.ref009]\].

HSV-1 encodes two transcription factors, VP16 \[[@ppat.1004939.ref010],[@ppat.1004939.ref011]\] and ICP4 \[[@ppat.1004939.ref012]\], which function along with the cellular RNA polymerase II transcription machinery \[[@ppat.1004939.ref013]\] to transcribe the viral genome. These factors initially colocalize with prereplicative genomes \[[@ppat.1004939.ref014]--[@ppat.1004939.ref016]\] and these interactions as well as those involving viral and cellular RNA-processing factors result in an ordered cascade of viral gene expression \[[@ppat.1004939.ref017],[@ppat.1004939.ref018]\]. Seven HSV gene products are sufficient in cells to replicate DNA in an HSV-origin dependent manner \[[@ppat.1004939.ref019]\]. While this set of viral proteins includes a DNA-dependent DNA polymerase and other functional analogs of cellular DNA replication proteins, it is not sufficient to drive origin-dependent replication *in vitro*, suggesting the requirement for as yet unknown cellular proteins \[[@ppat.1004939.ref020]\]. Finally, an additional set of proteins interacts with the genome in the processes of cleaving unit length genomes and their packaging in capsids \[[@ppat.1004939.ref021]\]. These processes have been, and continue to be the focus of studies in many laboratories since significant gaps exist in our understanding of all these processes, and how they ultimately contribute to viral multiplication and pathogenesis. A shortcoming contributing to these gaps is our relative lack of knowledge of the proteins, particularly cell-derived, which interact with viral genomes in different phases of infection.

Recently, ethynyl-modified nucleosides along with click chemistry and immunofluorescence were used to trace the fate of input adenovirus genomes in infected cells \[[@ppat.1004939.ref022]\]. Nucleoside analogs were also incorporated into replicating herpes simplex and vaccinia viral DNA to demonstrate that this technique can be used to label other viral genomes and could potentially be used to track these genomes throughout infection. In addition, ethynyl-modified nucleosides have been used in a procedure known as isolation of proteins on nascent DNA (iPOND) to identify the proteins at cellular replication forks \[[@ppat.1004939.ref023]--[@ppat.1004939.ref028]\]. This procedure involves the metabolic incorporation of 5-ethynyl-2´-deoxyuridine (EdU) into the DNA, biotinylating the EdU-labeled DNA by click chemistry, followed by the affinity purification of the biotinylated DNA, and the subsequent analysis of the proteins associated with it. We have adopted and modified these procedures to enable the visualization of the HSV genome at different stages of infection, as well as the interrogation of the viral and cellular proteins on replicated/replicating viral genomes. The results elucidate the viral and cellular proteins associating with viral DNA during infection and provide a comprehensive view of the cellular machinery functioning on HSV genomes.

Results {#sec002}
=======

Labeling and imaging HSV genomes {#sec003}
--------------------------------

Ethynyl-modified nucleosides have been used to prelabel and then track single incoming adenovirus genomes within infected cells \[[@ppat.1004939.ref022]\]. While this approach was also used to examine HSV genomes in replication compartments, input genomes were not imaged. We sought to determine if ethynyl-modified nucleosides could be used to label and track HSV genomes during early (before DNA replication), as well as late (after DNA replication) stages of infection. We also intended to use viral DNA imaging to optimize HSV genome labeling for purification of viral genomes by iPOND.

Preliminary experiments demonstrated that EdU and EdC were poorly incorporated in HSV DNA. We hypothesized that deletion of the HSV deoxyuridine triphosphatase (dUTPase) and uracil glycosylase enzymes would increase incorporation into the viral genome. HSV-1 uracil glycosylase and dUTPase mutant strains were generated by introducing premature termination codons early in the reading frames of the UL2 and UL50 genes (Fig A in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}). As found for labeling of adenovirus genomes \[[@ppat.1004939.ref022]\], ethynyl nucleoside incorporation into HSV genomes resulted in slightly reduced virus titers (Fig B in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}). The same concentrations of EdU or EdC had a greater effect on the titer of the UL2/UL50 double mutant virus than on wild type KOS, suggesting that the double mutant is more efficiently labeled by both EdU and EdC. EdU was used in all subsequent experiments.

To compare the relative amount of EdU incorporated into wild type and mutant genomes, we carried out viral infection and DNA imaging as outlined in [Fig 1A and 1B](#ppat.1004939.g001){ref-type="fig"}. EdU labeled input genomes and replication compartments were tagged with Alexa Fluor 488 by click chemistry and visualized by fluorescence microscopy ([Fig 2](#ppat.1004939.g002){ref-type="fig"}). Prelabeled UL2/UL50 mutant genomes that colocalized with the viral transcription factor, ICP4, were visualized in the nucleus of infected cells ([Fig 2A](#ppat.1004939.g002){ref-type="fig"}). The distribution of ICP4 foci two hours after infection largely resembles that observed previously after infection with HSV-1 at a MOI of 10 PFU/cell \[[@ppat.1004939.ref029]\]. Using these same conditions, we were unable to detect KOS genomes prelabeled with 2.5 μM EdU ([Fig 2A](#ppat.1004939.g002){ref-type="fig"}). We also visualized viral replication compartments that colocalize with ICP4 8 hpi in both wild type KOS and UL2/UL50 mutant virus infected cells ([Fig 2B](#ppat.1004939.g002){ref-type="fig"}). While it was possible to detect EdU labeling coinciding with ICP4 staining in KOS infected cells, significantly more was observed with the UL2/UL50 mutant. Taken together, the UL2/UL50 mutant virus incorporates more EdU into its genome during DNA replication and allows for more sensitive imaging of HSV-1 viral DNA during infection.

![Schematic representation of procedures used in this paper.\
(A) Resting MRC-5 cells in G~0~ were infected with either prelabeled (left) or unlabeled (right) virus. To assay unreplicated viral DNA (left), prelabeled genomes were processed less than four hpi. To assay viral replication compartments (right), EdU (orange stars) was added to the growth medium during viral DNA replication (≥ 4 hpi) and genomes were assayed 2--4 hours after the addition of EdU. EdU labeled DNA is orange. (B) Viral and cellular DNA, as well as viral and cellular proteins were labeled and visualized as described in the experimental procedures. DNA imaging experiments were carried out in proliferating Vero cells. Viral DNA is green. (C) and (D) iPOND and aniPOND experiments were carried out as described. aniPOND (accelerated native iPOND) is a modified version of iPOND that does not involve crosslinking and therefore requires less stringent wash conditions during purification.](ppat.1004939.g001){#ppat.1004939.g001}

![Visualization of EdU labeled HSV-1 genomes.\
(A) Prelabeled input viral genomes were visualized in the nucleus of infected cells 2 hpi. Vero cells were infected with wild type KOS or the UL2/UL50 mutant virus carrying unlabeled (0 μM) or prelabeled viral genomes. Labeled virus stocks were generated by growing KOS or UL2/UL50 mutant in the presence of 1.25 or 2.5 μM EdU as described in the experimental procedures. Cellular DNA was visualized by Hoechst staining, viral DNA by click chemistry with EdU, and ICP4 by immunofluorescence. Merged panels show colocalization of viral DNA with ICP4. Prelabeled KOS DNA could not be detected under these conditions. (B) Cells infected with KOS or UL2/UL50 mutant were grown in the presence of 0 or 2.5 μM EdU for 4--8 hpi. Uninfected cells were grown in the presence of EdU for 4 hours. DNA imaging was as described in (A).](ppat.1004939.g002){#ppat.1004939.g002}

Optimization and validation of HSV iPOND {#sec004}
----------------------------------------

To identify the viral and cellular proteins that function on viral DNA at different stages of infection, we adapted the iPOND method \[[@ppat.1004939.ref025]\] for analysis of viral genomes and associated proteins. To optimize viral iPOND, we initially considered several factors. Proliferating cells grown in the presence of EdU incorporate EdU into their genomes during DNA replication ([Fig 2B](#ppat.1004939.g002){ref-type="fig"}, uninfected, 2.5 μM). Therefore, conditions in which viral DNA, but not cellular DNA is labeled in the presence of EdU were established. Addition of EdU to the growth medium of proliferating Vero cells that were mock- or HSV-1-infected resulted in labeling of 65% or 29% of cellular genomes (Fig C in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}, panels Vero cells), respectively. HSV infection inhibits G1/S and G2/M phases of the cell cycle \[[@ppat.1004939.ref030],[@ppat.1004939.ref031]\] consistent with less labeling of cellular DNA in infected cells. In contrast to proliferating cells, less than 1% of cellular genomes were labeled with EdU when human MRC-5 fibroblast cells that were grown to confluency were infected with HSV in the presence of EdU (Fig C in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}, panels MRC-5 cells). Therefore, resting MRC-5 cells were used in iPOND experiments to avoid contamination with cellular DNA. These cells also have the added advantage that they are a natural host to lytic HSV infection and they do not express high levels of cellular glycosylases to limit cleavage of labeled viral genomes \[[@ppat.1004939.ref032]\].

One of the limitations of iPOND is that a large amount of EdU-labeled DNA is required to pull down enough protein for proteomic analysis \[[@ppat.1004939.ref025]\]. Because the UL2/UL50 mutant virus is more efficiently labeled with EdU than wild type virus, we hypothesized that more viral DNA and associated proteins could be purified by iPOND of the mutant virus. We tested iPOND for the purification of proteins associated with genomes of wild type KOS, UL2 and UL50 single mutant, and UL2/UL50 double mutant viruses (outlined in [Fig 1C](#ppat.1004939.g001){ref-type="fig"}). The relative protein yield for each virus was compared by western blot for the viral transcription factor ICP4 (Fig D in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}). ICP4 associates with viral genomes throughout infection and is a good indicator of protein yield. The negative control was iPOND carried out on virus-infected cells incubated in the absence of EdU. For all viruses tested, ICP4 was not detected in the negative control, but was detected when iPOND was carried out on viral genomes that were labeled with EdU. The greatest relative amount of ICP4 was detected with the UL2/UL50 mutant virus, consistent with fluorescence imaging of labeled viral genomes ([Fig 2B](#ppat.1004939.g002){ref-type="fig"}). Therefore, the UL2/UL50 mutant virus was used for iPOND experiments.

To identify the proteins associated with viral genomes by iPOND, we labeled viral DNA at three time points during DNA replication. EdU was added to the medium of infected cells at 4--6, 6--8, or 8--12 hpi and cells were fixed for iPOND at 6, 8, or 12 hpi, respectively. Proteins recovered by iPOND were probed for ICP4 by western blotting ([Fig 3A](#ppat.1004939.g003){ref-type="fig"}). ICP4 was detected at all time points, but not in the unlabeled negative control. To ensure that DNA isolated by iPOND was viral, input DNA from cell lysates and DNA bound to streptavidin-coated beads was extracted, the amount of viral DNA was measured, and the percentage of viral/total DNA was calculated ([Fig 3B](#ppat.1004939.g003){ref-type="fig"}). DNA eluted from beads during iPOND experiments was nearly 100% viral in nature. This is a significant enrichment compared to input DNA (0.2--1.5% viral). To determine if the entire viral genome was labeled and purified in our assays, high throughput DNA sequencing was carried out on DNA eluted from streptavidin-coated beads (Fig E in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}). At all time points, the distribution of bead-bound DNA was relatively homogeneous across the viral genome. Taken together, iPOND should enable the specific purification of proteins associated with the entire replicated HSV-1 genome.

![iPOND detects viral and cellular proteins associated with replicated HSV-1 genomes.\
(A) ICP4 was detected by western blot of protein eluates from iPOND carried out on viral genomes grown in the presence of EdU at 4--6, 6--8, and 8--12 hpi. The control was iPOND carried out on virus grown in the absence of EdU (−) and harvested 8 hpi. Purified ICP4 is shown. (B) DNA eluted from streptavidin-coated beads during iPOND experiments in (A) is viral. The amount of viral DNA present in cell lysates (input) and eluted from beads (bound) during iPOND experiments was measured by qRT-PCR of the viral thymidine kinase (TK) gene. The ratio of viral DNA (vDNA) to total DNA was calculated and is presented as log %vDNA. (C) Pie charts summarize proteins that were identified by mass spectrometry of protein eluates from iPOND carried out 6, 8, and 12 hpi with UL2/UL50 mutant virus. Values indicate the number of proteins identified for each functional category. (D) Venn diagrams depict the overlap of proteins identified by iPOND at each time point.](ppat.1004939.g003){#ppat.1004939.g003}

Factors that mediate host cell nuclear processes are enriched on HSV-1 genomes during viral DNA replication {#sec005}
-----------------------------------------------------------------------------------------------------------

To determine the identity of proteins bound to viral genomes at 6, 8, and 12 hpi, mass spectrometry was carried out on proteins that were crosslinked to viral DNA and purified by iPOND. Two independent iPOND experiments were carried out for each time point, each with an unlabeled virus negative control that was prepared on the same day with the same cells, virus, and reagents. Proteins were considered significantly enriched on viral genomes if they were identified with high confidence in duplicate experiments to be enriched by at least four fold over the negative control. The types of proteins identified at all three time points are summarized in [Fig 3C](#ppat.1004939.g003){ref-type="fig"} and individual complexes and proteins are listed in Tables [1](#ppat.1004939.t001){ref-type="table"}--[6](#ppat.1004939.t006){ref-type="table"} and Table A in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}. The most abundant types of proteins enriched on isolated viral DNA include those involved in RNA processing, transcription, chromatin remodeling, DNA repair, and DNA replication.

10.1371/journal.ppat.1004939.t001

###### HSV-1 proteins identified by iPOND and aniPOND.

![](ppat.1004939.t001){#ppat.1004939.t001g}

  HSV Proteins               iPOND (Mutant)                                      aniPOND (8hpi)                                                                               
  -------------------------- --------------------------------------------------- ---------------- ----- ----- ----- ----- ----- ----- ----- ----- ---- ----- ----- ---- ----- -----
  **Tegument**                                                                                                                                                                
  UL14                       TEG3                                                P04291           0     0     4     4     0     2     5     2     4    15    3     0    7     4
  UL21                       TEG4                                                P10205           14    0     5     22    2     0     5     41    3    22    18    0    7     6
  UL46                       TEG1                                                P10230           10    6     6     30    6     7     8     39    0    86    28    3    101   115
  UL47                       TEG5                                                P10231           35    5     78    317   44    16    117   340   49   188   120   16   173   209
  VP16                       Transcription factor                                P06492           4     11    16    85    21    6     52    108   9    86    81    13   127   158
  ICP0                       E3 ubiquitin-protein ligase                         P08393           0     0     0     6     0     0     3     22    0    9     15    0    7     69
  **Capsid**                                                                                                                                                                  
  UL38                       Triplex capsid protein VP19c                        P32888           25    33    36    109   8     20    78    178   7    4     8     0    12    34
  UL35                       Capsid protein VP26                                 P10219                                   0     0     0     4     0    7     3     0    5     10
  UL19                       Major capsid protein VP5                            P06491           151   302   284   588   137   239   376   615   66   93    129   18   219   262
  UL6                        Portal protein                                      P10190           5     11    21    28    0     7     9     21    0    93    4     4    180   94
  **Capsid Assembly**                                                                                                                                                         
  UL37                       Capsid assembly protein                             P10221           0     0     0     2     0     0     0     11    0    0     21    0    0     30
  UL26                       Capsid scaffolding protein VP22a                    P10210           0     6     7     40    0     6     16    34    0    0     5     3    6     15
  **Packaging proteins**                                                                                                                                                      
  UL17                                                                           P10201           0     0     9     18    0     9     22    44    0    9     12    0    16    25
  UL32                                                                           P10216           0     0     0     13    0     0     2     19    0    0     4     0    12    22
  UL25                                                                           P10209           0     0     13    42    4     0     17    55    0    0     3     0    2     0
  **Other viral proteins**                                                                                                                                                    
  UL2                        Uracil glycosylase                                  P10210                                                           0    0     16    0    0     47
  UL3                        Nuclear phosphoprotein                              P10221           0     0     14    21    2     0     9     46    3    68    12    2    26    26
  UL50                       Deoxyuridine 5\'-triphosphate nucleotidohydrolase   P10234           0     2     2     2     2     18    15    19    0    7     78    2    2     116
  UL13                       Serine/threonine-protein kinase                     P04290                                                           0    8     0     0    11    4
  UL31                       Virion egress protein                               P10215           2     0     12    32    0     0     6     35    0    4     7     0    5     24

Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values indicate spectral counts determined by mass spectrometry. Identified viral replication, transcription, and RNA processing factors are listed in Tables [2](#ppat.1004939.t002){ref-type="table"}, [3](#ppat.1004939.t003){ref-type="table"}, and [6](#ppat.1004939.t006){ref-type="table"}, respectively.

10.1371/journal.ppat.1004939.t002

###### Replication factors identified by iPOND and aniPOND.

![](ppat.1004939.t002){#ppat.1004939.t002g}

  Replication Factors                                                                    iPOND-MS (Replication forks)   iPOND (mutant)   aniPOND (8hpi)                                                                                        
  ----------------------------------- -------------------------------------------------- ------------------------------ ---------------- ---------------- ---- ---- ----- ----- ----- ----- ---- ----- ----- ----- ---- ----- ----- ---- ----- -----
  POLA1                               DNA polymerase alpha catalytic subunit             P09884                         \+               \+               \+                                                                                   
  POLA2                               DNA polymerase alpha subunit B                     Q14181                         \+               \+                                                                                                    
  PRIM2                               DNA primase large subunit                          P49643                         \+               \+               \+                                                                                   
  **DNA polymerase**                                                                                                                                                                                                                           
  POLD1                               DNA polymerase delta catalytic subunit             P28340                         \+               \+               \+   \+                                                                   0    2     0
  POLD2                               DNA polymerase delta subunit 2                     P49005                         \+                                \+                                                                                   
  POLD3                               DNA polymerase delta subunit 3                     Q15054                         \+                                \+                                                                                   
  POLE                                DNA polymerase epsilon catalytic subunit A         Q07864                         \+               \+               \+   \+                                                                              
  **Clamp loader complex**                                                                                                                                                                                                                     
  RFC1                                Replication factor C subunit 1                     P35251                         \+               \+               \+   \+   0     2     2     0                            0    0     4     0    2     2
  RFC2                                Replication factor C subunit 2                     P35250                         \+               \+               \+   \+                                                  0    3     5     0    6     6
  RFC3                                Replication factor C subunit 3                     P40938                         \+               \+               \+   \+                                                  0    0     4     0    4     11
  RFC4                                Replication factor C subunit 4                     P35249                         \+               \+               \+   \+                                                  0    4     6     0    7     8
  RFC5                                Replication factor C subunit 5                     P40937                         \+               \+               \+   \+                                                  0    4     3     0    9     7
  **Replisome associated proteins**                                                                                                                                                                                                            
  LIG1                                DNA ligase 1                                       P18858                         \+               \+               \+   \+                                                                              
  RPA1                                Replication protein A 70 kDa DNA-binding subunit   P27694                         \+               \+               \+        0     7     0     3     0    0     2     9     0    0     0     0    14    22
  TOP1                                DNA topoisomerase 1                                P11387                                                                     0     58    65    69    9    68    67    115   16   96    176   0    299   357
  TOP2a                               DNA topoisomerase 2-alpha                          P11388                                                                     0     5     19    41    0    21    29    37    0    31    35    0    81    129
  TOP2b                               DNA topoisomerase 2-beta                           Q02880                         \+               \+                         0     46    64    107   9    70    83    106   3    104   98    0    165   317
  PCNA                                Proliferating cell nuclear antigen                 P12004                         \+               \+               \+   \+   0     20    18    4     0    27    11    6     7    90    63    7    148   124
  **MCM complex (helicase)**                                                                                                                                                                                                                   
  MCM2                                DNA replication licensing factor MCM2              P49736                         \+               \+               \+                                0    0     0     2                                 
  MCM3                                DNA replication licensing factor MCM3              P25205                         \+               \+               \+        0     4     5     20    0    0     4     4                                 
  MCM4                                DNA replication licensing factor MCM4              P33991                         \+                                \+                                                                                   
  MCM5                                DNA replication licensing factor MCM5              P33992                                                           \+        0     4     4     7     0    0     2     6                                 
  MCM6                                DNA replication licensing factor MCM6              Q14566                         \+               \+               \+                                                                                   
  MCM7                                DNA replication licensing factor MCM7              P33993                         \+               \+               \+        0     0     4     2                                                        
  **HSV replication machinery**                                                                                                                                                                                                                
  ICP8                                Major DNA binding protein                          P04296                                                                     107   627   395   866   84   395   467   791   87   389   362   42   494   527
  UL30                                Polymerase                                         P04293                                                                     31    178   207   309   26   170   253   320   65   185   408   23   364   683
  UL5                                 Helicase/primase                                   P10236                                                                     5     59    67    91    2    34    42    71                                
  UL8                                 Helicase/primase                                   P10192                                                                     0     0     9     18    0    0     0     9                                 
  UL52                                Helicase/primase                                   P10236                                                                     0     42    25    54    0    31    44    60                                
  UL9                                 Oriigin binding protein                            P10193                                                                     0     34    21    66    0    36    45    90    8    219   201   22   390   406
  UL42                                Processivity factor                                P10226                                                                     81    298   230   492   72   237   307   519   79   357   286   92   483   619

Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values indicate spectral counts determined by mass spectrometry. Cellular replication fork iPOND-MS data was reported previously as follows: A \[[@ppat.1004939.ref028]\], B \[[@ppat.1004939.ref026]\], C \[[@ppat.1004939.ref023]\].

10.1371/journal.ppat.1004939.t003

###### Transcription factors identified by iPOND and aniPOND.

![](ppat.1004939.t003){#ppat.1004939.t003g}

  **Transcription Factors**                         **iPOND (Mutant)**                                            **aniPOND (8hpi)**                                                                                
  ------------------------------------------------- ------------------------------------------------------------- -------------------- ---- ----- ----- ----- ---- ----- ----- ----- ----- ----- ----- ----- ------ ------
  POLR2A                                            DNA-directed RNA polymerase II subunit RPB1                   P24928               0    33    36    7     0    95    49    48    0     54    10    0     111    74
  POLR2B                                            DNA-directed RNA polymerase II subunit RPB2                   P30876               0    20    40    4     0    97    61    51    0     31    3     0     87     50
  POLR2C                                            DNA-directed RNA polymerase II subunit RPB3                   P19387               0    0     2     0     0    5     0     2     0     2     2     0     6      10
  POLR2D                                            DNA-directed RNA polymerase II subunit RPB4                   O15514               0    0     2     0                            0     2     0     0     2      0
  POLR2E                                            DNA-directed RNA polymerases II subunit RPB5                  P19388               0    3     7     2     0    3     0     2     0     4     3     0     6      7
  POLR2F                                            DNA-directed RNA polymerases II subunit RPB6                  P61218                                                             0     2     0                  
  POLR2G                                            DNA-directed RNA polymerase II subunit RPB7                   P62487               0    2     0     0                            0     5     0     0     7      5
  POLR2H                                            DNA-directed RNA polymerases II subunit RPB8                  P52434                                                                               0     2      2
  POLR2I                                            DNA-directed RNA polymerase II subunit RPB9                   P36954                                                                               0     7      2
  POLR2J                                            DNA-directed RNA polymerase II subunit RPB11-a                P52435                                      0    2     2     0                                    
  POLR2L                                            DNA-directed RNA polymerases II subunit RPB10                 P62875                                      0    2     0     0                                    
  **Mediator of RNA polymerase II transcription**                                                                                                                                                                   
  MED1                                              Mediator of RNA polymerase II transcription subunit 1         Q15648                                                             0     6     8     0     52     32
  MED4                                              Mediator of RNA polymerase II transcription subunit 4         Q9NPJ6                                                             0     2     0     0     7      6
  MED6                                              Mediator of RNA polymerase II transcription subunit 6         O75586                                                             0     4     0     0     12     7
  MED7                                              Mediator of RNA polymerase II transcription subunit 7         O43513                                                                               0     7      0
  MED8                                              Mediator of RNA polymerase II transcription subunit 8         Q96G25                                                                               0     7      5
  MED10                                             Mediator of RNA polymerase II transcription subunit 10        Q9BTT4                                                                               0     4      0
  MED11                                             Mediator of RNA polymerase II transcription subunit 11        Q9P086                                                                               0     3      2
  MED12                                             Mediator of RNA polymerase II transcription subunit 12        Q93074                                                             0     14    0     0     82     46
  MED13                                             Mediator of RNA polymerase II transcription subunit 13        Q9UHV7                                                                               0     6      0
  MED13L                                            Mediator of RNA polymerase II transcription subunit 13-like   Q71F56                                                                               0     11     0
  MED14                                             Mediator of RNA polymerase II transcription subunit 14        O60244                                                             0     22    10    0     156    119
  MED15                                             Mediator of RNA polymerase II transcription subunit 15        Q96RN5                                                                               0     15     3
  MED16                                             Mediator of RNA polymerase II transcription subunit 16        Q9Y2X0                                                             0     18    9     0     51     31
  MED17                                             Mediator of RNA polymerase II transcription subunit 17        Q9NVC6                                                             0     9     5     0     37     27
  MED18                                             Mediator of RNA polymerase II transcription subunit 18        Q9BUE0                                                             0     3     3     0     12     6
  MED20                                             Mediator of RNA polymerase II transcription subunit 20        Q9H944                                                             0     6     4     0     11     11
  MED21                                             Mediator of RNA polymerase II transcription subunit 21        Q13503                                                             0     2     0     0     4      2
  MED22                                             Mediator of RNA polymerase II transcription subunit 22        Q15528                                                                               0     4      3
  MED23                                             Mediator of RNA polymerase II transcription subunit 23        Q9ULK4                                                             0     59    27    0     132    110
  MED24                                             Mediator of RNA polymerase II transcription subunit 24        O75448                                                             0     35    12    0     83     65
  MED25                                             Mediator of RNA polymerase II transcription subunit 25        Q71SY5                                                                               0     16     16
  MED27                                             Mediator of RNA polymerase II transcription subunit 27        Q6P2C8                                                             0     4     2     0     16     17
  MED28                                             Mediator of RNA polymerase II transcription subunit 28        Q9H204                                                             0     2     2     0     3      4
  MED29                                             Mediator of RNA polymerase II transcription subunit 29        Q9NX70                                                             0     3     2     0     8      10
  MED30                                             Mediator of RNA polymerase II transcription subunit 30        Q96HR3                                                             0     4     0     0     7      4
  MED31                                             Mediator of RNA polymerase II transcription subunit 31        Q9Y3C7                                                             0     7     6     0     13     8
  CCNC                                              Cyclin-C                                                      P24863                                                             0     2     3     0     6      5
  CDK8                                              Cyclin-dependent kinase 8                                     P49336                                                                               0     8      10
  **Transcription initiation factor TFIID**                                                                                                                                                                         
  TAF1                                              Transcription initiation factor TFIID subunit 1               P21675                                                                               0     5      12
  TAF2                                              Transcription initiation factor TFIID subunit 2               Q6P1X5                                                             0     9     0     0     18     25
  TAF3                                              Transcription initiation factor TFIID subunit 3               Q5VWG9                                                                               0     0      3
  TAF4                                              Transcription initiation factor TFIID subunit 4               O00268                                                                               0     5      0
  TAF5                                              Transcription initiation factor TFIID subunit 5               Q15542                                                             0     8     2     0     62     45
  TAF6                                              Transcription initiation factor TFIID subunit 6               P49848                                                             0     20    6     0     48     41
  TAF9                                              Transcription initiation factor TFIID subunit 9               Q16594                                                                               0     8      10
  TAF9B                                             Transcription initiation factor TFIID subunit 9B              Q9HBM6                                                             0     8     3     0     6      0
  TAF10                                             Transcription initiation factor TFIID subunit 10              Q12962                                                             0     2     0     0     2      2
  TAF12                                             Transcription initiation factor TFIID subunit 12              Q16514                                                             0     4     0     0     2      3
  TAF15                                             TATA-binding protein-associated factor 2N                     Q92804                                                                                            
  TBP                                               TATA-box binding protein                                      P20226                                                                               0     12     17
  **Transcription initiation factor TFIIH**                                                                                                                                                                         
  XPB                                               TFIIH basal transcription factor complex helicase ERCC3       P19447                                                             0     0     9     0     39     60
  XPD                                               TFIIH basal transcription factor complex helicase ERCC2       P18074                                                             0     0     4     0     36     45
  CDK7                                              Cyclin-dependent kinase 7                                     P50613                                                                               0     15     19
  MAT1                                              CDK-activating kinase assembly factor MAT1                    P51948                                                                               0     8      9
  CCNH                                              Cyclin-H                                                      P51946                                                             0     0     2     0     8      9
  GTF2H1                                            General transcription factor 2H subunit 1                     P32780                                                                               0     6      14
  GTF2H2                                            General transcription factor 2H subunit 2                     Q6P1K8                                                             0     2     6     0     21     38
  GTF2H3                                            General transcription factor 2H subunit 3                     Q13889                                                             0     0     3     0     13     13
  GTF2H4                                            General transcription factor 2H subunit 4                     Q92759                                                             0     0     5     0     17     36
  **Viral transcription regulators**                                                                                                                                                                                
  VP16                                              Tegument protein VP16                                         P06492               4    11    16    85    21   6     52    108   9     86    81    13    127    158
  ICP4                                              Major viral transcription factor                              P08392               46   300   199   247   31   259   266   366   133   613   585   113   1146   1255
  ICP22                                             Transcriptional regulator ICP22                               P04485               8    60    18    46    6    51    69    74    0     26    17    0     29     44
  **Other cellular transcription factors**                                                                                                                                                                          
  TRIM28                                            Transcription intermediary factor 1-beta                      Q13263               0    130   94    117   3    81    121   162   0     26    19    0     121    181
  CTCF                                              Transcriptional repressor CTCF                                P49711                                      0    2     6     24    0     26    12    0     41     54
  TFII-I                                            General transcription factor II-I                             P78347               0    69    61    73    0    35    49    73    0     3     0     0     21     10
  SPT5                                              Transcription elongation factor SUPT5H (DSIF component)       O00267               0    25    7     6     0    33    20    27    0     15    2     0     37     21
  SPT6                                              Transcription elongation factor SUPT6H                        Q7KZ85               0    5     6     0     0    28    10    14    0     17    0     0     38     14
  CSK21                                             Casein kinase II subunit alpha                                P68400                                                             0     7     3     0     9      12
  CSK2B                                             Casein kinase II subunit beta                                 P67870                                                             0     6     2     2     10     7
  FUBP1                                             Far upstream element-binding protein 1                        Q96AE4               2    25    32    47    7    32    31    39                                   
  FUBP2                                             Far upstream element-binding protein 2                        Q92945               9    41    22    46    6    27    32    38                                   
  MATR3                                             Matrin-3                                                      P43243               0    52    41    69    0    41    50    105   0     2     0     0     16     5
  BCLF1                                             Bcl-2-associated transcription factor 1                       Q9NYF8               0    0     14    15    0    12    13    29    10    23    14    16    54     47
  CDC5L                                             Cell division cycle 5-like protein                            Q99459               0    0     11    10    0    4     11    17    0     2     0     0     8      5
  NONO                                              Non-POU domain-containing octamer-binding protein             Q15233               18   85    90    123   22   85    121   133   31    67    60    8     88     75
  CN166                                             UPF0568 protein C14orf166                                     Q9Y224               0    9     5     10    0    2     3     14    0     2     6     0     7      16

Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values indicate spectral counts determined by mass spectrometry.

10.1371/journal.ppat.1004939.t004

###### Chromatin remodeling factors and histones identified by iPOND and aniPOND.

![](ppat.1004939.t004){#ppat.1004939.t004g}

  Chromatin Remodeling Factors                      iPOND (Mutant)                                   aniPOND (8hpi)                                                                        
  ------------------------------------------------- ------------------------------------------------ ---------------- ---- ---- ---- ---- ----- ----- ----- ----- --- ---- ---- ---- ----- -----
  SUPT16h                                           FACT complex subunit SPT16                       Q9Y5B9           0    74   61   47   0     77    51    47    0   15   14   0    8     38
  SSRP1                                             FACT complex subunit SSRP1                       Q08945           0    47   42   37   0     35    29    49    0   5    18   0    9     41
  **INO80 complex**                                                                                                                                                                        
  INO80                                             DNA helicase (KIAA1259)                          Q9ULG1                                                       0   6    0    0    26    27
  ARP5                                              Actin-related protein 5                          Q9H9F9                                                       0   3    0    0    3     3
  ARP8                                              Actin-related protein 8                          Q9H981                                                                     0    9     13
  RUVBL1                                            RUVB-like 1 (TIP49A)                             Q9Y265           8    46   40   47   0     13    21    24    0   93   39   0    104   112
  RUVBL2                                            RUVB-like 2 (TIP49B)                             Q9Y230           2    12   17   15   0     9     6     24    0   57   34   0    65    79
  **NURD complex**                                                                                                                                                                         
  CHD3                                              Chromodomain-helicase-DNA-binding protein 3      Q12873                               0     0     0     9     0   0    9    0    23    41
  CHD4                                              Chromodomain-helicase-DNA-binding protein 4      Q14839           0    28   22   42   0     36    35    61    0   57   77   0    81    124
  HDAC1                                             Histone deacetylase 1                            Q13547                                                       0   32   15   0    25    24
  HDAC2                                             Histone deacetylase 2                            Q92769           0    0    0    6    0     12    8     22    0   9    0    0    79    79
  RBBP4                                             Histone-binding protein RBBP4 (RbAp48)           Q09028           0    31   13   17   0     35    22    40    0   40   17   0    50    62
  MTA1                                              Metastasis-associated protein MTA1               Q13330           0    0    0    11   0     3     5     3     0   21   10   0    45    28
  MTA2                                              Metastasis-associated protein MTA2               O94776           0    11   19   23   0     5     11    19    0   27   22   0    61    67
  **SWI/SNF complex**                                                                                                                                                                      
  ARID1A                                            BAF250A (Swi1)                                   O14497           0    0    0    6    0     3     5     3     0   4    10   0    9     21
  SMARCA4                                           BRG1 (Swi2/Snf2)                                 P51532           0    13   10   0    0     11    22    22    0   29   20   0    51    91
  SMARCC1                                           BAF155 (Swi3)                                    Q92922           0    0    0    3    0     0     7     8     0   17   0    0    22    21
  SMARCC2                                           BAF170 (Swi3)                                    Q8TAQ2           0    16   12   24   0     13    22    26    0   31   25   0    61    100
  SMARCD2                                           Swp73                                            Q92925                                                       0   3    3    0    3     12
  ACTL6A                                            BAF53 (Swp61)                                    O96019           0    8    6    6    0     0     0     2     0   7    8    0    26    38
  SMARCB1                                           BAF47 (Snf5)                                     Q12824                                                       0   7    4    0    3     12
  SMARCE1                                           BAF57                                            Q969G3           0    0    0    2    0     0     0     2     0   2    0    0    8     4
  **COMPASS lysine methyltransferase complex**                                                                                                                                             
  RBBP5                                             Retinoblastoma binding protein 5                 Q15291                                                       0   9    5    0    31    27
  WDR82                                             WD repeat-containing protein 82                  Q6UXN9           0    0    4    7    0     4     0     7                   0    12    10
  WDR5                                              WD repeat-containing protein 5                   P61964           0    0    2    2                            0   4    7    0    20    25
  ASH2L                                                                                              Q9UBL3                                                       0   2    0    0    3     6
  HCFC1                                             Host cell factor 1                               P51610           0    0    4    0    0     0     0     6                   0    6     11
  MLL1                                              Histone-lysine N-methyltransferase 2A (Set1)     Q03164                                                       0   6    0    0    2     2
  **Chromatin/DNA modifying enzymes**                                                                                                                                                      
  DNMT1                                             DNA methyltransferase 1                          P26358           0    6    3    2    0     11    14    4     0   0    4    0    0     7
  PRMT1                                             Protein arginine methyltransferase 1 (ANM1)      Q9Y3Y2           2    20   15   30   2     21    15    29                             
  NAT10                                             N-acetyltransferase 10                           Q9H0A0           0    0    4    10   0     4     8     12    0   5    5    0    11    3
  MBB1A                                             Myb-binding protein 1A (HDAC activity)           Q9BQG0           0    0    4    7    0     7     15    22    0   73   21   0    13    10
  KDM1A                                             Lysine-specific histone demethylase 1A (LSD1A)   O60341           0    3    0    4    0     0     2     0     0   21   13   0    62    64
  APOBEC3C                                          DNA dC---\> dU editing enzyme                    Q9NRW3                                                       0   11   7    0    6     8
  **Chromatin associated and remodeling factors**                                                                                                                                          
  HMGB1                                             High mobility group box 1                        P09429           3    57   45   98   29    107   116   148                 2    9     11
  HMGB2                                             High mobility group box 2                        P26583           0    12   0    6    0     28    26    46                  0    3     6
  CBX3                                              Chromobox homolog 3                              Q13185           0    6    3    4    0     8     12    17    0   7    0    0    5     5
  SMARCA5                                           hSNF2H                                           O60264           0    35   27   27   0     25    24    37    0   51   37   0    54    84
  SMHD1                                             SMC hinge domain-containing protein 1            A6NHR9           0    41   42   23   0     43    31    42    0   28   37   0    106   111
  DEK                                                                                                P35659           0    2    2    13   3     20    14    21    0   11   13   0    57    42
  **Histones**                                                                                                                                                                             
  H1.2                                              Histone H1.2                                     \|P16403         23   66   65   47   154   181   180   184   0   53   29   36   146   140
  H1.4                                              Histone H1.4                                     P10412                               115   142   142   156   0   26   30   11   153   135

Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values indicate spectral counts determined by mass spectrometry.

10.1371/journal.ppat.1004939.t005

###### Cellular repair proteins identified by iPOND and aniPOND.
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  Repair Proteins                iPOND (Mutant)                                           aniPOND (8hpi)                                                                      
  ------------------------------ -------------------------------------------------------- ---------------- --- ----- ---- ----- --- ---- ---- ----- --- ----- ----- --- ----- -----
  KU80                           XRCC5                                                    P13010           6   106   79   104   2   88   96   120   0   32    23    0   38    51
  KU70                           XRCC6                                                    P12956           0   79    64   103   0   42   52   85    0   8     10    0   24    46
  **MRN complex---DSB repair**                                                                                                                                                
  RAD50                          Repair protein Rad50                                     Q92878           0   49    51   41    0   84   83   66    0   6     6     0   144   84
  MRE11                          Meiotic recombination 11 homolog                         P49959           0   8     6    11    0   25   11   32                    0   15    8
  NBS1                           Nibrin                                                   O60934                                0   2    0    0                     0   2     2
  **Mismatch repair**                                                                                                                                                         
  MSH2                           MutS homolog 2                                           P43246           0   35    37   18    0   28   17   25    0   69    28    0   105   63
  MSH3                           MutS homolog 3                                           P20585                                                    0   7     16    0   67    51
  MSH6                           MutS homolog 6                                           P52701           0   22    17   11    0   27   19   27    0   48    0     0   64    0
  MLH1                           MutL homolog 1                                           P40692           0   0     4    0     0   2    0    0                               
  **Base excision repair**                                                                                                                                                    
  PARP1                          Poly \[ADP-ribose\] polymerase 1                         P09874           0   40    50   70    0   35   42   60    6   108   108   0   296   265
  XRCC1                          X-ray repair cross-complementing protein 1               P18887           0   0     8    0     0   0    6    4     0   2     19    0   33    43
  LIG3                           DNA ligase 3                                             P49916           0   4     2    2     0   3    0    0     0   19    43    0   157   145
  UL2                            Viral uracil DNA glycosylase                             Q1KMD3                                                    0   0     16    0   0     47
  APEX                           DNA-(apurinic or apyrimidinic site) lyase                P27695           0   9     9    10    0   15   13   19    0   0     2     0   0     8
  **Cohesin complex**                                                                                                                                                         
  SMC3                           Structural maintenance of chromosomes protein 3          Q9UQE7           0   73    92   105   0   57   82   111   0   150   113   0   149   238
  SMC1A                          Structural maintenance of chromosomes protein 1A         Q14683           0   71    63   72    0   40   58   91    0   142   56    0   131   223
  STAG1                          SCC3A                                                    Q8WVM7           0   0     0    2     0   0    9    10    0   63    42    0   44    67
  STAG2                          SCC3B                                                    Q8N3U4                                0   0    6    4     0   30    20    0   33    47
  RAD21                          SCC1                                                     O60216                                0   0    6    9     0   9     0     0   17    42
  PDS5B                          Cohesin complex interacting protein                      Q9NTI5           0   3     0    12    0   22   27   55    0   42    50    0   107   158
  **Other repair proteins**                                                                                                                                                   
  RECQL                          ATP-dependent DNA helicase Q1                            P46063           0   29    26   52    0   28   26   55    2   32    115   2   184   304
  ATM                            Ataxia telangiectasia mutated                            Q13315           0   14    8    6     0   28   12   11    0   3     0     0   111   67
  TRRAP                          Transformation/transcription domain-associated protein   Q9Y4A5                                0   0    0    2     0   34    18    0   141   113
  DNA-PKcs                       DNA-dependent protein kinase catalytic subunit           P78527           0   11    2    17    0   27   44   46    0   8     45    0   119   138

Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values indicate spectral counts determined by mass spectrometry.

10.1371/journal.ppat.1004939.t006

###### RNA processing factors identified by iPOND and aniPOND.
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  RNA Processing Factors                         iPOND (Mutant)                                                  aniPOND (8hpi)                                                                              
  ---------------------------------------------- --------------------------------------------------------------- ---------------- ---- ----- ----- ----- ----- ----- ----- ----- ---- ----- ----- ---- ----- -----
  THOC1                                          THO complex subunit 1                                           Q96FV9                                                          0    6     6     0    14    25
  THOC2                                          THO complex subunit 2                                           Q8NI27           0    18    3     19    0     0     5     12    0    39    18    0    88    66
  THOC3                                          THO complex subunit 3                                           Q96J01                                                          0    3     0     0    7     12
  THOC4                                          THO complex subunit 4                                           Q86V81           0    0     0     2     13    21    20    23    16   8     10    51   65    80
  THOC5                                          THO complex subunit 5                                           Q13769                                                          0    2     0     0    21    17
  THOC6                                          THO complex subunit 6                                           Q86W42                                                          0    6     4     0    17    21
  THOC7                                          THO complex subunit 7                                           Q6I9Y2                                                          0    6     0     0    6     5
  **Heterogeneous nuclear ribonucleoproteins**                                                                                                                                                               
  hnRNP AB                                       Heterogeneous nuclear ribonucleoprotein A/B                     Q99729           0    43    23    46    8     31    20    41    5    28    4     0    22    25
  hnRNP A0                                       Heterogeneous nuclear ribonucleoprotein A0                      Q13151           0    0     7     14    7     15    11    30    5    13    0     0    16    21
  hnRNP A1                                       Heterogeneous nuclear ribonucleoprotein A1                      P09651           34   110   82    127   87    170   155   243   73   177   107   35   137   135
  hnRNP A2/B1                                    Heterogeneous nuclear ribonucleoproteins A2/B1                  P22626           30   88    69    124   93    183   174   248   74   235   100   33   180   199
  hnRNP A3                                       Heterogeneous nuclear ribonucleoprotein A3                      P51991           0    35    11    51    42    101   70    144   10   138   37    27   117   100
  hnRNP C                                        Heterogeneous nuclear ribonucleoproteins C1/C2                  P07910           40   134   123   176   38    116   114   176   53   174   71    55   135   127
  hnRNP DL                                       Heterogeneous nuclear ribonucleoprotein D-like                  O14979           0    8     4     24    7     15    30    37    0    5     4     4    11    10
  hnRNP D                                        Heterogeneous nuclear ribonucleoprotein D0                      Q14103           11   59    37    68    29    90    59    128   2    41    15    3    65    57
  hnRNP F                                        Heterogeneous nuclear ribonucleoprotein F                       P52597           2    5     23    6     4     41    41    63                                
  hnRNP H                                        Heterogeneous nuclear ribonucleoprotein H                       P31943           29   91    74    106   52    140   116   173   27   92    55    0    98    79
  hnRNP H2                                       Heterogeneous nuclear ribonucleoprotein H2                      P55795           0    0     11    42    0     17    0     59                     0    7     0
  hnRNP H3                                       Heterogeneous nuclear ribonucleoprotein H3                      P31942           0    0     17    16    7     34    18    28    10   34    10    3    22    16
  hnRNP L                                        Heterogeneous nuclear ribonucleoprotein L                       P14866           16   61    57    79    50    73    93    112   38   127   58    14   123   98
  hnRNP M                                        Heterogeneous nuclear ribonucleoprotein M                       P52272           32   162   121   155   25    128   137   165   20   150   34    2    80    55
  hnRNP U                                        Heterogeneous nuclear ribonucleoprotein U                       Q00839           48   161   114   195   105   183   235   267   28   105   71    16   127   121
  hnRNP UL1                                      Heterogeneous nuclear ribonucleoprotein U-like protein 1        Q9BUJ2           0    17    8     19    0     19    16    17                                
  hnRNP UL2                                      Heterogeneous nuclear ribonucleoprotein U-like protein 2        Q1KMD3           2    21    18    29    4     31    29    53    4    36    10    5    63    60
  **RNA helicases**                                                                                                                                                                                          
  DDX3X                                          ATP-dependent RNA helicase DDX3X                                O00571           9    12    2     15    0     2     0     0     3    28    21    2    19    26
  DDX5                                           Probable ATP-dependent RNA helicase DDX5                        P17844           15   80    70    105   6     65    61    78    24   78    72    6    65    59
  DDX17                                          Probable ATP-dependent RNA helicase DDX17                       Q92841           9    80    74    92    27    87    94    98    0    18    11    0    24    22
  DDX23                                          Probable ATP-dependent RNA helicase DDX23                       Q9BUQ8           0    2     13    14    0     4     6     8     0    24    6     0    42    36
  DDX42                                          ATP-dependent RNA helicase DDX42                                Q86XP3           0    0     8     5     0     12    10    15                                
  DDX46                                          Probable ATP-dependent RNA helicase DDX46                       Q7L014           0    4     7     16    0     0     10    14                     0    20    13
  DHX15                                          Putative splicing factor ATP-dependent RNA helicase             O43143           0    30    30    44                            0    38    6     0    32    12
  DHX9                                           ATP-dependent RNA helicase A                                    Q08211           31   106   103   143   31    96    103   123   44   153   87    7    99    87
  **Splicing factors**                                                                                                                                                                                       
  ELAV1                                          ELAV-like protein 1                                             Q15717           0    9     11    16    6     17    19    20    7    49    8     5    38    17
  KIAA1967                                       DBIRD complex subunit                                           Q8N163           0    0     10    4     0     2     6     11                     0    0     2
  LA                                             Lupus LA protein                                                P05455           0    3     6     8     0     6     3     21                                
  LEG1                                           Galectin 1                                                      P09382           6    23    17    31    9     40    27    45    7    10    11    14   24    28
  MAGOHB                                         Protein mago nashi homolog 2                                    Q96A72           0    0     0     2     0     6     5     6     3    15    4     0    10    4
  PRP6                                           Pre-mRNA-processing factor 6                                    O94906           0    3     6     4     2     8     9     16    4    24    21    0    96    84
  PRP8                                           Pre-mRNA-processing-splicing factor 8                           Q6P2Q9           0    45    53    87    8     54    74    93    13   126   73    0    249   198
  PRP19                                          Pre-mRNA-processing factor 19                                   Q9UMS4           0    26    34    30    0     9     26    43    0    16    11    3    46    36
  PRP40A                                         Pre-mRNA-processing factor 40 homolog A                         O75400           0    9     19    13    0     10    10    23    0    17    10    0    46    38
  RALY                                           RNA-binding protein Raly                                        Q9UKM9           7    26    47    49    8     52    46    61    22   99    30    10   40    38
  SF3A1                                          Splicing factor 3A subunit 1                                    Q15459           0    7     6     20    0     10    16    18    0    5     4     0    27    30
  SF3A3                                          Splicing factor 3A subunit 3                                    Q12874           0    0     5     5     0     6     12    20    0    4     4     0    11    2
  SF3B1                                          Splicing factor 3B subunit 1                                    O75533           0    24    35    50    0     23    25    40    9    39    14    0    46    30
  SF3B2                                          Splicing factor 3B subunit 2                                    Q13435           0    16    23    10    0     13    18    20    0    3     0     5    20    20
  SF3B3                                          Splicing factor 3B subunit 3                                    Q15393           0    29    23    31    2     35    33    41    7    60    19    21   124   105
  SF3B14                                         Pre-mRNA branch site protein p14                                Q9Y3B4           0    2     4     10    0     0     5     11    2    7     0     0    8     6
  SNRPA1                                         U2 small nuclear ribonucleoprotein A\'                          P09661           0    7     9     10    0     10    7     14    3    4     8     4    13    10
  SNRPB                                          Small nuclear ribonucleoprotein-associated proteins B and B\'   P14678           0    18    2     18    23    36    19    47    2    24    4     4    36    30
  SR140                                          U2 snRNP-associated SURP motif-containing protein               O15042           0    9     13    15    0     6     12    16    0    14    0     0    9     3
  SRSF1                                          Serine/arginine-rich splicing factor 1                          Q07955           0    14    8     18    10    41    28    55    15   53    27    14   65    47
  SRSF2                                          Serine/arginine-rich splicing factor 2                          Q01130           0    3     7     20    5     15    22    41    0    11    6     2    15    16
  SRSF6                                          Serine/arginine-rich splicing factor 6                          Q13247           4    8     12    22    9     34    29    40    28   73    45    13   62    62
  SRSF7                                          Serine/arginine-rich splicing factor 7                          Q16629           0    8     14    15    4     13    15    40    12   69    22    14   42    33
  SRSF9                                          Serine/arginine-rich splicing factor 9                          Q13242                                  0     9     8     20    4    27    9     6    26    19
  SRSF10                                         Serine/arginine-rich splicing factor 10                         O75494                                  0     0     2     2     0    5     0     0    6     5
  TRA2A                                          Transformer-2 protein homolog alpha                             Q13595                                                          0    14    4     4    22    21
  TRA2B                                          Transformer-2 protein homolog beta                              P62995           0    4     2     16    3     18    17    22    13   59    18    9    50    45
  U2AF1                                          Splicing factor U2AF 35 kDa subunit                             Q01081           0    14    5     19    0     19    14    26    0    0     2     0    6     7
  U2AF2                                          Splicing factor U2AF 65                                         P26368           0    0     5     11    0     0     7     13                                
  U520                                           U5 small nuclear ribonucleoprotein 200 kDa helicase             O75643           0    47    54    96    7     38    45    57    15   93    55    8    149   121
  U5S1                                           116 kDa U5 small nuclear ribonucleoprotein component            Q15029           0    28    10    26    0     12    18    25    3    46    17    0    77    58
  **Other RNA processing factors**                                                                                                                                                                           
  ADAR                                           Double-stranded RNA-specific adenosine deaminase (DSRAD)        P55265           0    2     9     12    0     2     9     12    0    56    6     0    21    10
  SRRT                                           Serrate RNA effector molecule homolog                           Q9BXP5           0    14    16    23    0     12    21    33    5    30    16    0    48    43
  IMDH2                                          Inosine-5\'-monophosphate dehydrogenase 2                       P12268                                                          0    14    0     0    13    0
  CPSF1                                          Cleavage and polyadenylation specificity factor subunit 1       Q10570                                                          0    14    4     0    27    7
  PABP1                                          Polyadenylate-binding protein 1                                 P11940           13   15    37    47    9     33    30    64    26   147   46    2    123   49
  PABP4                                          Polyadenylate-binding protein 4                                 Q13310           0    0     3     4     0     5     10    18    0    44    8     0    30    0
  NCBP1                                          Nuclear cap binding protein 1                                   Q09161           0    2     2     9     0     0     2     5     0    7     0     0    8     9
  ILF3                                           Interleukin enhancer-binding factor 3                           Q12906           4    33    26    48    48    106   92    134   21   111   52    24   133   90

Experiments, conditions, and complexes are indicated in bold. Columns 1, 2, and 3 include protein name, description, and accession number. Values indicate spectral counts determined by mass spectrometry.

Furthermore, proteins that mediate nuclear transport, components of the nuclear cytoskeleton, and HSV structural proteins were bound to viral genomes. Several trends are present in these data. First, the total number of proteins that were recovered increased with time of infection. This is consistent with increasing amounts of labeled DNA as replication proceeds, allowing for more sensitive detection of bound proteins. Second, there was a relative increase in proteins that function in post-transcriptional RNA processing, as well as viral structural proteins with time. The increase in viral structural proteins including tegument proteins, capsid assembly factors, portal protein (UL6), and capsid proteins reflects the packaging of nascent genomes at later times during infection ([Table 1](#ppat.1004939.t001){ref-type="table"}).

Comparison of proteins identified at each time point suggests that the individual proteins found on replicated/replicating viral genomes at 6, 8, and 12 hpi were relatively similar ([Fig 3D](#ppat.1004939.g003){ref-type="fig"}). There are significant overlaps between the three different time points with most proteins identified at two or more of the times sampled. The biggest difference was seen at 12 hpi and this reflects the increase in structural proteins, as well as the larger number of proteins recovered by iPOND at this time point.

Comparative analysis of replication proteins found on replicated cellular and viral DNA reveals the specificity of isolation of proteins on viral DNA ([Table 2](#ppat.1004939.t002){ref-type="table"}). Cellular replication forks are enriched for cellular replication factors including components of cellular DNA polymerase, clamp loader complex, MCM complex, as well as other replisome-associated proteins such as topoisomerases and PCNA \[[@ppat.1004939.ref023],[@ppat.1004939.ref026],[@ppat.1004939.ref028]\]. In contrast, in our studies viral DNA was enriched for all seven components of the viral replication machinery including: ICP8, UL30 (polymerase), UL5/UL8/UL52 (helicase/primase complex), UL9 (origin binding protein), and UL42 (processivity factor). The cellular counterparts to these viral proteins were not enriched on viral genomes. One exception to this is the cellular processivity factor, PCNA. This protein was enriched on viral genomes at all times tested with the highest levels at 6 hpi, decreasing with time. Furthermore, cellular topoisomerases TOP1, TOP2a, and TOP2b were abundant on viral genomes and likely play a role in virus replication or other process.

aniPOND is an alternative method to purify viral genomes and associated proteins {#sec006}
--------------------------------------------------------------------------------

Accelerated native iPOND (aniPOND) is a modified version of iPOND that is quicker and does not utilize crosslinking \[[@ppat.1004939.ref033]\]. It involves native conditions during purification, while iPOND involves crosslinking and stringent wash conditions ([Fig 1C and 1D](#ppat.1004939.g001){ref-type="fig"}). We therefore predicted that aniPOND would reveal a unique set of proteins involved in viral genome mechanics compared to iPOND because less direct interactors could be detected.

To obtain a more comprehensive view of proteins bound to viral genomes, we carried out aniPOND on KOS and UL2/UL50 mutant viruses that were incubated in the presence of EdU from 4--8 hpi and harvested at 8 hpi. Proteins eluted from viral DNA during aniPOND were assayed for ICP4 by western blotting ([Fig 4A](#ppat.1004939.g004){ref-type="fig"}). ICP4 was detected when the infection was carried out in the presence of EdU (lanes 3 and 4), but not in the absence of EdU (lane 1). Importantly, using aniPOND it was also possible to recover ICP4 associated with wild type genomes, however, greater amounts where recovered in the sample with the mutant virus extract. In this experiment, significantly less (\~2%) sample was required to isolate a similar amount of ICP4 to that recovered with iPOND. Therefore aniPOND is more efficient for the recovery of labeled viral DNA and associated proteins than iPOND. This is in agreement with comparison of the purification of replisome-associated proteins by each method \[[@ppat.1004939.ref033]\].

![aniPOND detects viral and cellular proteins associated with replicated viral genomes.\
(A) ICP4 was detected in protein eluates from aniPOND experiments carried out on wild type KOS or UL2/UL50 mutant virus by western blotting. AniPOND was carried out on virus grown in the presence (+) or absence (-) of 2.5 μM EdU at 4--8 hpi and/or 33 μM acycloguanosine (ACG) throughout infection. (B) DNA eluted from streptavidin-coated beads during aniPOND experiments in (A) is viral. The amount of viral DNA present in cell lysates (input) and eluted from beads (bound) during aniPOND experiments was measured by qPCR of the viral TK gene. The ratio of viral DNA (vDNA) to total DNA was calculated and is presented in log %vDNA. Values for virus grown in the presence of ACG are too small to be displayed on this graph. These experiments were carried out with the UL2/UL50 mutant virus. (C) Pie charts summarize proteins that were identified by mass spectrometry of protein eluates from aniPOND carried out on the UL2/UL50 mutant grown in the presence of EdU at 4--8 hpi. Pie charts represent proteins that were identified with high confidence in independent duplicate experiments. Values indicate the number of proteins identified for each functional category. (D) Venn diagrams depict the overlap of proteins identified by iPOND and aniPOND carried out on the UL2/UL50 mutant 8 hpi.](ppat.1004939.g004){#ppat.1004939.g004}

To verify the specificity of aniPOND for the purification of replicated viral genomes, we carried out aniPOND on cells infected with the UL2/UL50 mutant virus that was maintained in the presence of acycloguanosine (ACG, acyclovir), a potent inhibitor of viral DNA replication. In the absence of viral DNA replication, DNA was not recovered by aniPOND and ICP4 was not detected by western blotting ([Fig 4A](#ppat.1004939.g004){ref-type="fig"}, lane 2). To further validate aniPOND for purification of viral genomes, we determined the relative amount of viral DNA/total DNA purified by this method. DNA eluted from beads during aniPOND experiments was almost 100% viral in nature ([Fig 4B](#ppat.1004939.g004){ref-type="fig"}, bound DNA, +EdU-ACG). This is a significant enrichment compared to the percent viral DNA present in lysates for this condition (input DNA, \<2%). Very little DNA was detected when aniPOND was carried out on virus grown in the absence of EdU (bound DNA,-EdU) or in the presence of ACG (+ACG), consistent with specific purification of replicated viral DNA by aniPOND.

To determine the identity of proteins that copurified with viral genomes, mass spectrometry was carried out on samples prepared by aniPOND of labeled UL2/UL50 mutant and wild type KOS genomes at 8 hpi. Two independent experiments were carried out for each virus, with an unlabeled virus negative control that was done on the same day with the same cells and reagents. Almost twice as many proteins were identified with high confidence by aniPOND compared to iPOND at 8 hpi (184 compared to 96). The types of proteins identified by aniPOND are summarized in [Fig 4C](#ppat.1004939.g004){ref-type="fig"} and individual proteins are listed in Tables [1](#ppat.1004939.t001){ref-type="table"}--[6](#ppat.1004939.t006){ref-type="table"} and Table A in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}. Proteins that copurified with viral genomes by aniPOND at 8 hpi share the same functional categories as proteins that were purified by iPOND. In fact, pie charts that summarize the findings from these two experiments show very similar trends (compare Figs [4C](#ppat.1004939.g004){ref-type="fig"} to [3C](#ppat.1004939.g003){ref-type="fig"} 8hpi).

Proteins that copurified with UL2/UL50 mutant genomes by iPOND and aniPOND at 8 hpi were compared ([Fig 4D](#ppat.1004939.g004){ref-type="fig"}). Fifty-three proteins were identified by both methods, 131 by only aniPOND, and 43 by only iPOND. Differences in proteins identified by each method likely reflect differences in the nature of DNA-protein interactions. For example, the viral helicase/primase complex was identified by iPOND but not aniPOND ([Table 2](#ppat.1004939.t002){ref-type="table"}). Crosslinking during iPOND could capture transient DNA-protein interactions or interactions that are lost during purification, which may be the case for ATPases such as the helicase/primase complex. On the other hand, the mediator of RNA polymerase II complex, as well as components of general transcription factor TFIID and TFIIH were identified by aniPOND but not iPOND ([Table 3](#ppat.1004939.t003){ref-type="table"}). Members of these complexes may not be in direct contact with the viral genome or may bind in an orientation that is not conducive to crosslinking. We have shown previously that the mediator complex, TFIID, and TFIIH copurify with ICP4 from virus-infected cells \[[@ppat.1004939.ref034],[@ppat.1004939.ref035]\]. Here we also confirmed that ICP4 coprecipitates with mediator and TFIID from virus infected resting MRC-5 cells, along with a subset of transcription and chromatin remodeling factors that copurify with viral DNA (Table B in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}). Therefore, ICP4 may provide a means to target these complexes to viral DNA.

Comparison of proteins identified by aniPOND of mutant genomes and wild type genomes (Tables [1](#ppat.1004939.t001){ref-type="table"}--[6](#ppat.1004939.t006){ref-type="table"}, Mutant vs. KOS) reveal similar trends and in almost all cases the same proteins were found to be associated with both genomes. In fact, the most obvious difference is that viral peptides for UL2 and UL50 gene products were not enriched on UL2/UL50 mutant genomes but were enriched on wild type genomes ([Table 1](#ppat.1004939.t001){ref-type="table"}). This provides validation for these mutants not expressing UL2 and UL50 gene products and supports the use of mutant genomes for the purification and identification of virus-associated proteins.

To provide support for the specificity of iPOND and aniPOND methods for the purification of bona fide viral genome associated proteins, we searched the Contaminant Repository for Affinity Purification (CRAPome) \[[@ppat.1004939.ref036]\] for cellular proteins identified by these methods (Fig F in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}). This web-based database includes 411 datasets of common contaminants present in negative controls for protein purification. Most proteins that were identified in this study were found in less than 20% of the negative control datasets, consistent with specific enrichment of viral genome associated proteins by these methods.

Taken together, aniPOND is an alternative method for the purification of virus-associated proteins and may be more useful in situations were few genomes are present (for example before DNA replication) or when genomes are not efficiently labeled with nucleoside analogs (for example wild type KOS). Furthermore, the combination of both methods reveals a comprehensive look at proteins associated with viral genomes.

Cellular factors relocalize to viral replication compartments during HSV infection {#sec007}
----------------------------------------------------------------------------------

To better visualize the reorganization of host nuclear factors to viral replication compartments during lytic infection with HSV, we used immunofluorescence to compare the distribution of cellular factors in the nucleus of mock-infected cells to cells infected with KOS for 8 hours ([Fig 5](#ppat.1004939.g005){ref-type="fig"}). Ten cellular proteins that were identified by iPOND and/or aniPOND, including replication proteins PCNA and TOP2, transcription factors TFII-I, Spt5, Spt6, and XPD, chromatin remodeling factors SSRP1, HMGB1, and HDAC2, as well as the repair protein Ku70 were tested for colocalization with viral DNA. In all cases, the cellular proteins relocalized to viral replication compartments. Interestingly, these cellular factors were relocated from multiple locations within the nucleus. Taken together, it is clear that HSV infection induces gross reorganization of the host nucleus and compartmentalization of cellular factors that likely participate in multiple aspects of the virus life cycle.

![Proteins identified to interact with HSV-1 genomes by iPOND and aniPOND relocalize to viral replication compartments during lytic infection.\
Vero cells infected with wild type KOS were grown in the presence of 10 μM EdU at 4--8 hpi. Cellular DNA was visualized by Hoechst staining, viral replication compartments (vDNA) by click chemistry with EdU, and cellular proteins by immunofluorescence at 8 hpi (panels KOS, 8 hpi). Mock infected cells (panels Mock) display the normal distribution of cellular proteins in the nucleus in the absence of HSV infection. For KOS infected cells, the first merged panel displays colocalization of viral DNA with cellular proteins. The second merged panel shows the localization of viral DNA and cellular proteins with respect to cellular DNA.](ppat.1004939.g005){#ppat.1004939.g005}

HSV genomes are deficient for histones during lytic infection {#sec008}
-------------------------------------------------------------

Micrococcal nuclease digestion assays indicate that packaged genomes are not associated with nucleosomes, only a small portion of incoming unreplicated genomes are associated with nucleosomes, and newly replicated genomes are not associated with nucleosomes \[[@ppat.1004939.ref037]--[@ppat.1004939.ref039]\]. However, ChIP mapping data indicate that histones are bound to many HSV promoters and genes, and often have marks of active chromatin \[[@ppat.1004939.ref040],[@ppat.1004939.ref041]\]. The working model is that histones are present on viral genomes during early lytic infection, the distribution and density of histones on lytic genomes is significantly less than the host genome, and histones likely play a role in the regulation of viral gene expression. In contrast, latent genomes are associated with ordered chromatin similar to host cell DNA \[[@ppat.1004939.ref042]\].

Many components of chromatin remodeling complexes were identified on replicated viral genomes by iPOND and aniPOND ([Table 4](#ppat.1004939.t004){ref-type="table"}). These include members of the FACT, INO80, NURD, and SWI/SNF chromatin remodeling complexes, as well as DNA and chromatin modifying enzymes. However, histones were not enriched on purified replicated genomes, with the exceptions of a few histone H1 variants, which were also abundant in negative controls ([Table 4](#ppat.1004939.t004){ref-type="table"} and Fig F in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}). Perhaps chromatin remodeling factors associate with viral DNA to facilitate the removal of histones or to keep histones from binding to newly replicated genomes.

To provide support for the absence of histones on replicating genomes, colocalization of viral genomes with histones was assayed by fluorescence microscopy. EdU-labeled viral replication compartments were tagged with Alexa Fluor 488 and either histone H1 (all subtypes; [Fig 6A](#ppat.1004939.g006){ref-type="fig"}) or H3 (6B) was labeled with specific antibodies for immunofluorescence. Less dense localization of both histones was observed with viral DNA relative to cellular DNA. This localization pattern greatly contrasts the pattern observed for proteins that were identified to associate with viral genomes ([Fig 5](#ppat.1004939.g005){ref-type="fig"}). These data support iPOND and aniPOND results and confirm that histones are not enriched on viral genomes during DNA replication.

![Histones H1 and H3 do not colocalize with replicated HSV genomes.\
(A) Infected Vero cells were maintained in the presence of EdU at 4--8 hpi. Cellular DNA was visualized by Hoechst staining, viral replication compartments by click chemistry with EdU, and histone H1 by immunofluorescence. Merged panels show the lack of colocalization of viral DNA with histone H1. Uninfected cells are shown as a control for normal histone distribution in the nucleus. (B) Imaging was carried out as in (A) except that immunofluorescence was carried out with antibodies specific for histone H3.](ppat.1004939.g006){#ppat.1004939.g006}

To assay for the colocalizaiton of viral genomes with histones during early lytic infection, fluorescence imaging of prelabeled incoming viral genomes was carried out at 2 hpi ([Fig 7](#ppat.1004939.g007){ref-type="fig"}). Histones H1 and H3 did not colocalize with incoming viral genomes, at least within limits of detection by immunofluorescence. This is in stark contrast to the pattern of ICP4 colocalization with incoming genomes. In conclusion, iPOND, aniPOND, and imaging data provide support for a deficiency of histones on viral genomes throughout lytic infection

![Histones H1 and H3 do not colocalize with incoming HSV genomes.\
Vero cells infected with KOS virus (prelabeled with 10 μM EdU) were assayed for colocalization with histones H1 and H3 at 2 hpi. Nuclei are shown with incoming viral genomes visualized by click chemistry with EdU, and histone H1, histone H3, or ICP4 by immunofluorescence. Merged panels show the lack of colocalization of viral DNA with histones and robust colocalization with ICP4.](ppat.1004939.g007){#ppat.1004939.g007}

Discussion {#sec009}
==========

In this study, we adapted procedures that have been used to label and purify cellular replication forks to label and purify replicating HSV-1 genomes. We have engineered mutant HSV strains that increase EdU incorporation into replicating viral genomes allowing for more sensitive imaging and purification of viral DNA. We are the first to label HSV DNA to track the fate of incoming viral genomes within an infected cell, demonstrating its colocalization with ICP4 expressed from those genomes. We have optimized the iPOND and aniPOND methods to study HSV genomes during different stages of the HSV life cycle by these methods. From these studies we have compiled a comprehensive list of proteins that are selectively recruited to HSV genomes during and after viral DNA replication. By imaging the relocalization of several of these factors to viral replication compartments during infection, we have demonstrated the extent to which host nuclei are largely reorganized during viral infection. Finally, we show that viral genomes isolated by iPOND and aniPOND have a relatively low abundance of histones, which is consistent with the lack of colocalization of genomes with histones H1 and H3. Data presented in this paper provide a comprehensive view of viral and cellular proteins that associate with replicating HSV genomes during productive infection and provide insight into how HSV manipulates host cell nuclear machineries for the expression, replication, and maintenance of its genome.

In this study, we identified \>200 viral and cellular proteins that are associated with HSV genomes after the onset of DNA replication. The overall most abundant proteins found on the genome include the viral transcription factor ICP4 ([Table 3](#ppat.1004939.t003){ref-type="table"}), and the viral replication proteins UL29 (ICP8, major DNA binding protein), UL30 (viral DNA polymerase), and UL42 (processivity factor) ([Table 2](#ppat.1004939.t002){ref-type="table"}). The identified cellular proteins function in host cell nuclear processes including DNA replication, repair, chromatin remodeling, transcription, RNA processing, and nuclear transport (Figs [3C](#ppat.1004939.g003){ref-type="fig"} and [4C](#ppat.1004939.g004){ref-type="fig"}).

Viral DNA replication {#sec010}
---------------------

In addition to UL29, UL30, and UL42, four other viral replication factors, UL9 (origin binding protein) and UL5/UL8/UL52 (helicase primase complex) were enriched on viral genomes. In contrast to iPOND studies of cellular replication forks \[[@ppat.1004939.ref023],[@ppat.1004939.ref026],[@ppat.1004939.ref028]\], most cellular DNA replication proteins did not copurify with viral genomes. However, the cellular processivity factor PCNA and topoisomerases TOP1, TOP2a, and TOP2b were reproducibly enriched on replicating viral genomes. iPOND data indicate that the levels of PCNA on viral genomes is higher at 6 hpi than at 8 and 12 hpi, suggesting that PCNA may play a role in early phases of viral DNA replication. Topoisomerases are important for relaxing supercoiled DNA as a consequence of helicase unwinding during replication and transcription \[[@ppat.1004939.ref043]\], and likely carryout this same function on viral DNA. PCNA ([Fig 5](#ppat.1004939.g005){ref-type="fig"})\[[@ppat.1004939.ref044]\] and Top2 ([Fig 5](#ppat.1004939.g005){ref-type="fig"}) redistribute to viral replication compartments during viral DNA replication, however a direct role in HSV replication has yet to be demonstrated. Currently, there is not a good system to study origin-primed viral DNA replication *in vitro* \[[@ppat.1004939.ref020]\]. It is possible that cellular PCNA or topoisomerases are the missing players in these reconstitution assays.

The DNA damage response, repair, and recombination {#sec011}
--------------------------------------------------

We also identified several components involved in double strand break (DSB) recognition and repair associated with replicating viral genomes in our assays. These include Ku70 and Ku80, the Mre11/Rad50/Nbs1 (MRN) complex, ataxia telangiectasia mutated (ATM), and the catalytic subunit of DNA dependent protein kinase (DNA-PKcs) ([Table 5](#ppat.1004939.t005){ref-type="table"}). Ku70 ([Fig 5](#ppat.1004939.g005){ref-type="fig"}) and Ku80 \[[@ppat.1004939.ref045]\] colocalize with viral replication compartments. However, Ku70 expression is inhibitory for viral DNA replication \[[@ppat.1004939.ref045]\]. Perhaps, these proteins participate in a cellular antiviral response in attempt to control virus multiplication.

The MRN complex, ATM, and activation of the DNA damage response are beneficial for HSV genome replication \[[@ppat.1004939.ref046]--[@ppat.1004939.ref048]\]. The MRN complex and ATM are recruited to viral replication compartments and ATM is activated through autophosphorylation to trigger the DNA damage response and cell cycle arrest through multiple pathways. In this way, the cell recognizes the viral genome as DNA damage. However, downstream binding of cellular proteins that mediate repair through nonhomologous end joining (NHEJ) and homologous recombination (HR) pathways are inhibited by the actions of the viral E3 ubiquitin ligase, ICP0 \[[@ppat.1004939.ref049]--[@ppat.1004939.ref051]\]. ICP0 targets downstream factors in these double strand break repair pathways for degradation, including DNA-PKcs, RNF8, and RNF168. Consistent with these data, we did not identify RNF8 or RNF168 to be recruited to viral DNA in our assays. Purification of DNA-PKcs is not inconsistent with these observations because only 50% of DNA-PKcs is degraded by ICP0 and this is likely cell type specific \[[@ppat.1004939.ref045]\]. These data support a scenario whereby viral genomes trigger the DNA damage response and cell cycle arrest to create an environment that is conducive to viral DNA replication. ICP0 may inhibit the actions of cellular HR and NHEJ pathways for the repair of virus ends, as well as nicks and gaps that occur during viral DNA replication. It is possible that HSV-1 instead uses its own machinery for recombination and repair during DNA replication, mediated by the actions of ICP8 and UL12 (alkaline nuclease) \[[@ppat.1004939.ref052],[@ppat.1004939.ref053]\]. In fact, UL12 has been shown to interact with components of the MRN complex and may therefore act with the MRN complex to carryout virus specific recombination \[[@ppat.1004939.ref054]\].

The structural maintenance of chromosomes (SMC) family of ATPases function to stabilize and organize chromosomes during mitosis \[[@ppat.1004939.ref055]\]. Of these complex members, SMC1 and SMC3, which make up the core of the cohesion complex, reproducibly copurify with replicating viral genomes. The cohesion complex is essential for sister chromatid cohesion during mitosis, but also plays a role in transcription and DNA repair by recombination \[[@ppat.1004939.ref056]\]. Cohesin complex proteins SMC3 and Rad21 have previously been shown to associate with Epstein-Barr virus genomes \[[@ppat.1004939.ref057],[@ppat.1004939.ref058]\]. Perhaps these proteins are involved in HSV gene expression or recombination during DNA replication. Mismatch repair \[[@ppat.1004939.ref059]\] and base excision repair \[[@ppat.1004939.ref060]\] pathways also function in maintaining HSV genomes, and specific factors involved in both of these types of repair were found to be associated with viral genomes in this study ([Table 5](#ppat.1004939.t005){ref-type="table"}).

RNA processing {#sec012}
--------------

RNA processing factors involved in all steps in pre-mRNA processing including capping, splicing, polyadenylation, and export were abundant on viral genomes ([Table 6](#ppat.1004939.t006){ref-type="table"}). Interestingly, ICP27, an essential viral immediate early gene product that regulates all steps in viral RNA processing \[[@ppat.1004939.ref061]\] was not readily detectable on genomes. However, the TREX complex was found in our studies, which has been shown to interact with ICP27 \[[@ppat.1004939.ref062],[@ppat.1004939.ref063]\] and to be involved in the export of KSHV intronless mRNAs \[[@ppat.1004939.ref064]\]. RNA helicases, which are involved in all aspects of RNA metabolism, as well as components of the nuclear transport machinery were also found associated with viral genomes. The abundant isolation of all of these RNA processing factors is most likely consistent with the high level accumulation of viral mRNA late after infection and the fact that transcription and RNA processing are coupled \[[@ppat.1004939.ref065]--[@ppat.1004939.ref067]\].

Chromatin remodeling and transcription {#sec013}
--------------------------------------

Multiple components of several chromatin remodeling complexes were enriched on viral genomes including the FACT, INO80, NURD, and SWI/SNF complexes ([Table 4](#ppat.1004939.t004){ref-type="table"}). This is consistent with proteomic analysis of proteins bound to ICP4 extracted from virus infected cells, in which components of INO80, NURD, and SWI/SNF complexes were identified \[[@ppat.1004939.ref034]\]. One of the FACT complex members, SPT16, was shown to copurify with ICP8 in the absence of DNAse treatment \[[@ppat.1004939.ref045]\] and here we demonstrated the redistribution of the other FACT complex member SSRP1 to viral replication compartments ([Fig 5](#ppat.1004939.g005){ref-type="fig"}). As discussed above, histones were not enriched on viral genomes, raising the possibility that these complexes maintain a nucleosome or histone free state, greatly facilitating processes such as replication and transcription on the genome. The FACT complex has been shown to disrupt nucleosome structure and allow DNA and RNA polymerases to access the DNA \[[@ppat.1004939.ref068]\], the INO80 complex mediates nucleosome sliding \[[@ppat.1004939.ref069]\], the NURD complex has both histone deacetylase and nucleosome remodeling functions \[[@ppat.1004939.ref070]\], and high mobility group (HMG) proteins, which are also found on viral genomes, have been shown to increase accessibility of chromatin-bound DNA \[[@ppat.1004939.ref071]\]. Furthermore, the INO80 and FACT complexes have also been implicated in cellular DNA damage repair by homologous recombination \[[@ppat.1004939.ref072],[@ppat.1004939.ref073]\], and may therefore also play roles in mechanisms of viral DNA recombination. HMGB1 was previously shown to function as a coactivator for ICP4 mediated transcription *in vitro* \[[@ppat.1004939.ref074]\], and may therefore function to mediate promoter specific activation of viral genes.

RNA polymerase II (polII) was abundant on isolated viral genomes ([Table 3](#ppat.1004939.t003){ref-type="table"}), with RPB1 and RPB2 being the most enriched subunits, most likely because they make direct contact with DNA during transcription \[[@ppat.1004939.ref075]\]. The transcription elongation factors Spt5, Spt6 \[[@ppat.1004939.ref076]\], and Trim28 \[[@ppat.1004939.ref077]\] were also found associated with viral genomes and Spt5 and Spt6 were shown to relocalize to viral replication compartments ([Fig 5](#ppat.1004939.g005){ref-type="fig"}). These are therefore likely candidates to regulate elongation during HSV transcription. TFII-I binds to initiator (inr) elements in cellular promoters \[[@ppat.1004939.ref078]\] and therefore may play a role in the expression of late viral genes.

The viral transcriptional regulators VP16, ICP4, and ICP22 were found on viral genomes by both iPOND and aniPOND. ICP22 was previously found to associate with ICP4 and RNA polII in transcription complexes \[[@ppat.1004939.ref079]\] and to mediate phosphorylation of polII \[[@ppat.1004939.ref080]\]. VP16 is a tegument protein that activates transcription of immediate early viral genes \[[@ppat.1004939.ref011]\]. ICP4 regulates expression from early and late HSV promoters and repression of immediate early promoters. It interacts with TFIID, TFIIH, and a specific form of the mediator complex that lacks Med26 and contains the kinase domain \[[@ppat.1004939.ref034],[@ppat.1004939.ref035]\]. Here we show that viral genomes copurified with subunits of TFIID, TFIIH, and the same form of the mediator complex that copurified with ICP4 from Vero \[[@ppat.1004939.ref034]\] and resting MRC-5 cells (Table B in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}). This form of mediator possesses the kinase domain, but lacks med26, and thus may be involved in repression, possibly of immediate early promoters late after infection. The viral genes transcribed late after infection all possess relatively simple TATA box-containing promoters, yet are abundantly transcribed. The accumulated data support a model where ICP4 plays an integral role in recruiting most of the key polII transcription factors, such as TFIID, required for abundant late transcription.

This study has provided a comprehensive view of the viral and cellular proteins associated with replicating HSV genomes and provides new insight into cellular mechanisms that regulate HSV infection. The presence of cellular proteins involved in a variety of nuclear processes is consistent with the rapid and high level of accumulation of viral transcripts, replicated genomes, and progeny virions shortly after infection. This must be accompanied by the recombination and repair of replicating genomes. It is probable that the association and function of these factors is facilitated by the relative dearth of cellular chromatin, which may be a function of the recruitment of multiple chromatin remodeling complexes. In this model, ICP4 binding to the genome, may have multiple roles in recruiting chromatin remodeling complexes and key polII transcription complexes, although a direct role of ICP4 in chromatin organization has yet to be demonstrated. What remains to be studied is to what extent this state is determined prior to the onset of viral DNA replication.

Materials and Methods {#sec014}
=====================

Cells and viruses {#sec015}
-----------------

Experiments were performed using MRC-5 (human embryonic lung) or Vero (African green monkey kidney) cells obtained from and propagated as recommended by ATCC. The viruses used in this study include the wild type HSV-1 strain, KOS, as well as UL2, UL50, and UL2/UL50 mutant viruses. Mutants were generated in bacterial artificial chromosomes (BACs) containing full-length, infectious KOS DNA \[[@ppat.1004939.ref081]\] using two-step red-mediated recombination \[[@ppat.1004939.ref082],[@ppat.1004939.ref083]\]. To generate the UL2 null virus, the cassette GGCTAGTTAACTAGCC, which contains a premature termination codon in all three reading frames, as well as an HpaI restriction site for validation, was inserted after the codon for cysteine 75 of the UL2 open reading frame. For the UL50 null virus, the codon for alanine 110 was replaced with this cassette. Mutant KOS-BAC constructs were transfected using Lipofectamine 2000 Transfection Reagent (Life Technologies) and propagated in Vero cells. Viral DNA was isolated from individual plaques \[[@ppat.1004939.ref084]\] and screened for mutations by Southern blotting \[[@ppat.1004939.ref085]\].

Preparation of prelabeled viral genomes {#sec016}
---------------------------------------

To generate prelabeled virus stocks, 1x10^8^ Vero cells were infected with unlabeled KOS or UL2/UL50 at an MOI of 10 PFU/cell at 37°C for 1 hour. After rinsing with tris-buffered saline (TBS) to remove unadsorbed virus, media was replaced with Dulbecco's Modified Eagle Medium (DMEM) containing 5% fetal bovine serum (FBS). Four hpi, EdU (Sigma-Aldrich) was added to the growth medium at the indicated concentration and incubated for an additional 34--36 hours. Monolayers were harvested, freeze-thawed three times at -80°C, sonicated, and clarified by low-speed centrifugation. Viral titers were determined by plaque assay on Vero cells.

Click chemistry and immunofluorescence {#sec017}
--------------------------------------

A total of 2x10^5^ Vero cells were grown on glass coverslips in 12-well dishes. Infections were carried out at an MOI of 10 in 100 μl TBS for 1 hour at room temperature. After infection, inoculum was removed and cells were rinsed with 1 ml TBS prior to addition of 1 ml DMEM plus 5% FBS. Infections were carried out at 37°C for the indicated period of time, with or without the addition of EdU to the growth medium. Cells were fixed with 3.7% formaldehyde for 15 min, washed two times with phosphate-buffered saline (PBS), permeabilized with 0.5% Triton-X 100 for 20 min, and blocked with 3% bovine serum albumin (BSA) for 30 min. EdU-labeled DNA was conjugated to Alexa Fluor 488 azide using the Click-iT EdU imaging kit according to manufacturer's protocol (Life Technologies). Cells were rinsed with PBS plus 3% BSA, then PBS, labeled with Hoechst 33342 (1:2000 dilution) for 30 min, washed two times with PBS, then incubated with primary antibody (mouse anti-ICP4: 58S, 1:500; mouse anti-histone H1: ab4269 (Abcam), 1:1000; rabbit anti-histone H3: ab1791 (Abcam), 1:1000; mouse anti-PCNA: sc-056 (Santa Cruz), 1:200; mouse anti-topoisomerase 2: NA14 (Calbiochem), 1:20; goat anti-TFII-I: sc-9943x (Santa Cruz), 1:200; rabbit anti-Spt5: A300-869A (Bethyl Laboratories), 1:200; rabbit anti-Spt6: ab32820 (Abcam), 1:200; rabbit anti-TFIIH p89 (XPD): sc-293 (Santa Cruz), 1:200; mouse anti-SSRP1: 10D1 (Biolegend), 1:200; rabbit anti-HMGB1: ab18256 (Abcam), 1:1000; rabbit anti-HDAC2: sc-7899 (Santa Cruz), 1:200; rabbit anti-Ku70: sc-9033 (Santa Cruz), 1:200) and Alexa Fluor 594-conjugated secondary antibodies (Santa Cruz, 1:500) as described previously \[[@ppat.1004939.ref034]\]. Images were obtained using an Olympus Fluoview FV1000 confocal microscope.

iPOND {#sec018}
-----

iPOND was carried out as described previously \[[@ppat.1004939.ref025]\] with the following modifications. For each condition, three 500 cm^2^ tissue culture dishes containing confluent monolayers of MRC-5 cells (\~7x10^7^ cells/dish) were infected with UL2/UL50 double mutant virus at an MOI of 10 PFU/cell for one hour at room temperature. After adsorption, the inoculum was removed and cells were rinsed with TBS before addition of fresh DMEM plus 5% FBS. Cells were incubated at 37°C for the indicated period of time before addition of EdU at a final concentration of 2.5 μM. After incubation for an additional 2--4 hours, cells were fixed with 1% (wt/vol) formaldehyde in PBS for 15 min at room temperature, quenched with 125 mM glycine, and harvested by scraping. Cell permeabilization, click chemistry, cell lysis, sonication, and streptavidin capture were carried out as described except the samples were sonicated 6 times for 30 sec each at 7 watts using a Cole-Palmer ultrasonic processor with microtip. For each condition, samples from three plates were combined, and proteins were eluted from streptavidin-coated beads by boiling in 200 μl 2x SDS Laemmli sample buffer to reverse formaldehyde crosslinks.

aniPOND {#sec019}
-------

aniPOND was carried out as described previously \[[@ppat.1004939.ref033]\] with the following modifications. For each condition, one 500 cm^2^ tissue culture dish containing a confluent monolayer of MRC-5 cells (\~7x10^7^ cells) was infected with wild type KOS or UL2/UL50 double mutant virus at an MOI of 10 PFU/cell for one hour at room temperature. After adsorption, the inoculum was removed and cells were rinsed with TBS before addition of fresh DMEM plus 5% FBS. Cells were incubated at 37°C for four hours before the addition of EdU (Sigma-Aldrich) at a final concentration of 2.5 μM, followed by an additional four-hour incubation. To detach the monolayer and extract nuclei, 20 ml nuclear extraction buffer was added directly to each plate, incubated at 4°C for 15 min, and harvested by scraping. Cell washes, click chemistry, cell lysis, sonication, and streptavidin capture were carried out as described except for cell lysis cells were incubated for 30 min total in lysis buffer and sonicated 8 times for 30 sec each at 7 watts. Proteins were eluted from streptavidin-coated beads by boiling in 66 μl 2x SDS Laemmli sample buffer. For aniPOND experiment 2, two plates of MRC-5 cells were used for analysis and for protein elution, streptavidin-coated beads from both samples were combined and proteins were eluted in 66 μl 2x sample buffer to generate a 2x concentrated sample.

Western blotting {#sec020}
----------------

SDS polyacrylamide gel electrophoresis and western blotting were carried out as described previously \[[@ppat.1004939.ref086]\]. Proteins were transferred to polyvinylidine fluoride membranes (Amersham) for chemi-luminescent detection with ECL reagent (Amersham). For detection of ICP4, membranes were probed with the 58S polyclonal mouse antibody (1:5000 dilution).

Mass spectrometry and data analysis {#sec021}
-----------------------------------

Mass spectrometry was carried out by MSBioworks. The entire sample was separated \~1.5cm on a 10% Bis-Tris Novex mini-gel (Invitrogen) using the MES buffer system. The gel was stained with coomassie and excised into ten equally sized segments. Gel segments were processed as described and analyzed by nano liquid chromatography with tandem mass spectrometry (LC/MS/MS) \[[@ppat.1004939.ref087]\]. Data were searched using Mascot and Mascot DAT files were parsed into the Scaffold software for validation, filtering, and to create a nonredundant list per sample. Data were filtered at 1% protein and peptide level false discovery rates and requiring at least two unique peptides per protein. Proteins were considered most significantly enriched by iPOND or aniPOND based on the following criteria: 1) protein had at least 5 spectral counts (SpC) in the experimental sample, 2) protein was not detected in the control or was enriched over the control by at least four-fold based on dividing SpC values, and 3) was detected in duplicate experiments. Raw SpC data without normalization are presented in Tables [1](#ppat.1004939.t001){ref-type="table"}--[6](#ppat.1004939.t006){ref-type="table"} and Table A in [S1 Text](#ppat.1004939.s001){ref-type="supplementary-material"}.

DNA isolation and quantitative real-time PCR (qRT-PCR) {#sec022}
------------------------------------------------------

DNA was isolated from 1/20^th^ volume cell lysates or 1/10^th^ volume streptavidin-coated beads during iPOND and aniPOND experiments. For isolation of DNA from cell lysates, an equal volume of 2x SDS-bicarb solution (2% SDS, 0.2 M NaHCO~3~) was added to the sample and for isolation of bead-bound DNA, beads were resuspended in 1x SDS-bicarb solution. Samples were incubated at 65°C overnight, followed by extraction with phenol:chloroform:isoamyl alcohol (25:24:1) and chloroform:isoamyl alcohol (24:1). DNA was recovered using the MinElute PCR Purification kit (Qiagen). DNA concentrations were measure using a Quibit Fluorometer and the Qubit dsDNA HS Assay Kit (Life Technologies).

qRT-PCR was carried out as described previously \[[@ppat.1004939.ref088]\]. The HSV-1 TK gene was amplified to estimate the amount of viral DNA in each sample. Primers used for amplification of the HSV TK gene were TkdsF1 (5´-ACCCGCTTAACAGCGTCAACA-3´) and TkdsR1 (5´-CCAAAGAGGTGCGGGAGTTT-3´). Standard curves were generated using purified KOS DNA.

Supporting Information {#sec023}
======================

###### Includes Supporting Materials and Methods, Supplemental Figures A-F, and Supplemental Tables A and B.
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